DEDICATED TO CAT OWNERS
Our Mission
To provide cat owners and veterinarians worldwide with the first officially registered, pharmaceutical-grade GS-441524 treatment, ensuring that “recovery” never has to be a gamble.
What Is NeoFipronis®?
NeoFipronis® (Pronidesivir) is an oral GS-441524 tablet for cats with FIP, officially registered in Laos to provide a clearer, more convenient, and traceable product option while reducing uncertainty from unclear-source products.
NeoFipronis® (Pronidesivir) 30mg GS-441524 Tablets for FIP in Cats
WHY WE ARE DIFFERENT
Why Choose NeoFipronis®?
NeoFipronis® combines oral GS-441524 tablets, official registration in Laos, batch traceability, and customer support to help cat owners choose a clearer and more reliable FIP support option.
GS-441524 Active Ingredient
Contains GS-441524, a key antiviral compound widely used in FIP treatment practice to help inhibit viral replication.
For Multiple FIP Types
Suitable for FIP support planning in wet, dry, ocular, and neurological cases under veterinary guidance.
Oral, Easier to Use
Oral tablets help reduce the stress, pain, and difficulty of daily injections during long treatment courses.
Registered and Traceable
Officially registered in Laos, with batch traceability and clearer product information for safer selection.
Long-Course Friendly
Designed for long FIP course management, with use and monitoring recommended under veterinary guidance.
Support Beyond Purchase
Provides product guidance, verification support, and customer assistance before and after ordering.
Submit your cat’s case or view product details to make a clearer decision.
PROFESSIONAL USE GUIDANCE
Dosage Reference and Important Notes
The following information is provided as a general reference for NeoFipronis® use in cats with FIP. Final use should be adjusted based on the cat’s condition and veterinary guidance.
DOSAGE REFERENCE
Standard FIP Cases
15 mg/kg, once daily. Give on an empty stomach, ideally 1 hour before food or 2 hours after food.
Neurological / Ocular Cases
30 mg/kg, once daily. Dose adjustment should be made under veterinary guidance according to severity.
Treatment Course
At least 12 weeks. Do not stop or reduce the dose without professional advice.
IMPORTANT NOTES
Not for human use or use in other animal species.
Monitor appetite, body temperature, and liver/kidney indicators during use.
Proper nutrition may help support immunity and recovery.
Keep sealed in a cool, dry place and protect from direct sunlight.
PRODUCT COMPARISON
NeoFipronis® vs. Injections / Black-Market 441
A clear comparison to help cat owners understand the differences in product qualification, administration, treatment support, safety, and after-sales guidance.
Swipe left to view full comparison →
| Comparison | NeoFipronis® | Traditional Injections | Black-Market Loose 441 |
|---|---|---|---|
| Product Qualification | Officially approved and traceable | No targeted treatment qualification | Unverified product with no assurance |
| Administration | Oral use, less stress | Daily injections, painful for cats | Dosage is difficult to control |
| Treatment Support | Targets FIP management with lower relapse risk | Symptom relief, prone to recurrence | Unstable effect, possible resistance risk |
| Safety | High purity, low side-effect risk | High stress and infection risk | High adulteration risk, possible liver/kidney burden |
| After-Sales Support | Full-course product-use guidance | No professional guidance | No after-sales support |
FAQ
Frequently Asked Questions
Find answers about NeoFipronis®, product information, verification support, batch traceability, and customer support.
Free diagnostics, round-the-clock support, and 12 weeks of dedicated follow-up. No service fees—you only cover the cost of medication.
Commitment to a cure. If symptoms return, we cover all costs for treatment and professional guidance.
Contact support before making a decision.
What is NeoFipronis®?
NeoFipronis® is an officially registered 30 mg oral tablet product for cats, with product verification support and batch traceability information.
Does NeoFipronis® contain GS-441524?
Yes. NeoFipronis® contains GS-441524, also referred to as Pronidesivir.
Is NeoFipronis® officially registered?
Registration-related information is available for review through the official website.
What is the regulatory class?
NeoFipronis® is listed as a non-prescription veterinary product in Laos.
Can I verify product information?
Yes. Product verification and batch-related support are available.
Can I contact support before ordering?
Yes. Customer support is available for product questions, verification details, and order-related assistance.
Should I consult a veterinarian?
Yes. Please consult a licensed veterinarian for decisions related to your cat’s health.
Disclaimer: The content on this page is for pet health education only and does not replace professional veterinary diagnosis. Please follow your veterinarian’s advice before using any medication.